SCHEMBL18064765

SCHEMBL18064765

N[C@H]1CCN(c2cc(Cl)ccc2C=O)C1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIM2 Q9P1W9 3/20 0.62
PIM1 P11309 2/20 0.62
PIM3 Q86V86 2/20 0.62
HTR3A P46098 1/20 0.48
MAT2A P31153 1/20 0.45
NOTUM Q6P988 2/20 0.44
HRH4 Q9H3N8 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 2/20 0.40
IRAK4 Q9NWZ3 1/20 0.39
SSTR2 P30874 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
ERN1 O75460 1/20 0.36
HTR2B P41595 1/20 0.35
HTR6 P50406 1/20 0.35
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
PAK4 O96013 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18064945 1.00 PIM2 (0.62) PIM2PIM1PIM3HTR3AMAT2A
SCHEMBL18064934 0.90 PIM2 (0.54) PIM2PIM1PIM3HTR3AMAT2A
SCHEMBL20769603 0.84 PIM1 (0.44) PIM2PIM1PIM3NOTUMTDP1
SCHEMBL20198169 0.83 TRPC3 (0.45) PIM2PIM1PIM3NOTUMTDP1
SCHEMBL19386343 0.83 PIM1 (0.45) PIM2PIM1PIM3HTR3AHRH4
SCHEMBL18064748 0.80 PIM1 (0.42) PIM2PIM1PIM3NOTUMMAPT
SCHEMBL23348993 0.79 TRPC3 (0.50) PIM2PIM1PIM3NOTUMTDP1
SCHEMBL18064770 0.78 L3MBTL1 (0.62) NOTUMMAPTIRAK4L3MBTL1HTR2B
SCHEMBL12282782 0.77 PIM2 (1.00) PIM2PIM1PIM3
SCHEMBL15093884 0.77 ALDH1A3 (0.53) TDP1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107660199-B Piperazine carbamates and methods of making and using the same H.隆德贝克有限公司 2021-11-23 CN disclosed
EP-3271352-B1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H LUNDBECK AS (DK) 2021-05-12 EP disclosed
US-9994537-B2 Piperazine carbamates and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2018-06-12 US disclosed
EP-3271352-A2 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME Abide Therapeutics, Inc. (US) 2018-01-24 EP disclosed
US-20170334874-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-11-23 US disclosed
US-9771341-B2 Piperazine carbamates and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2017-09-26 US disclosed
WO-2016149401-A2 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME ABIDE THERAPEUTICS, INC. (US) 2016-09-22 WO disclosed
US-20160272602-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2016-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272602-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME ABHD6, RABL6, ABHD16A PIM2 4457/4885PIM1 4678/4885PIM3 4115/4885
US-20170334874-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME ABHD6, RABL6, ABHD16A PIM2 4457/4885PIM1 4678/4885PIM3 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.